The plenary of the Chamber of Deputies approved this Thursday (10) the provisional measure 1.067/2021. It makes it mandatory for health plans to cover oral cancer drugs. The text had already been approved by the House in 2021, but returned for analysis after approval in the Senate with changes, and now goes to presidential sanction.
According to the proposal, the plans must provide treatment with so-called antineoplastics – drugs against cancer – as long as there is a medical prescription, a registration with the National Health Surveillance Agency (Anvisa) and the approval of the drug in the list of procedures and health events. supplement at the National Supplementary Health Agency (ANS).
The text determines that the drugs will need to be provided directly by patients or legal representatives within 10 days after the medical recommendation.
In the Senate, it was specified that the ANS will have a period of 120 days to analyze the incorporation of the drugs, which can be extended for another 60 days, which was maintained by the Chamber.
On Tuesday (8), the National Congress maintained President Jair Bolsonaro’s veto of a bill that had been approved on the same topic. The MP was the result of an agreement between the federal government and the private sector as an alternative to the presidential veto.
With information from Gabriela Vinhal, from CNN
Source: CNN Brasil
I am Sophia william, author of World Stock Market. I have a degree in journalism from the University of Missouri and I have worked as a reporter for several news websites. I have a passion for writing and informing people about the latest news and events happening in the world. I strive to be accurate and unbiased in my reporting, and I hope to provide readers with valuable information that they can use to make informed decisions.
